Immunohistochemical analysis and clinical course of high-malignant composite endocrine-acinar cell carcinoma: a case report.
Frank
M
M
Bittinger
A
A
Rothmund
M
M
Arnold
R
R
D018267:Carcinoma, Acinar Cell / Q000378:metabolism / Q000556:secondary* / Q000628:therapy; D018278:Carcinoma, Neuroendocrine / Q000378:metabolism / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006801:Humans; D007124:Immunoenzyme Techniques; D008113:Liver Neoplasms / Q000556:secondary* / Q000628:therapy; D008297:Male; D016253:Microscopy, Immunoelectron; D008875:Middle Aged; D009378:Neoplasms, Multiple Primary / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D010190:Pancreatic Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D012878:Skin Neoplasms / Q000556:secondary* / Q000628:therapy; D014362:Trypsinogen / Q000378:metabolism
D014362:Trypsinogen